Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk ...

External beam radiation therapy with or without short-term androgen deprivation showed 15-year survival benefits for ...

He revealed, “The aim of radiation therapy is to deliver a precise measured dose of radiation to a defined tumour volume with ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

Barry Goy, MD, provides insight into the clinical implications of a retrospective analysis examining 15-year outcomes in patients with intermediate-risk prostate cancer.

Radiation therapy is a cancer treatment that uses high doses of radiation to kill cancer cells Read on to learn how ...

The Vietnamese Ministry of Health has assigned three major hospitals -- K Hospital, Cho Ray Hospital, and Hue Central Hospital -- to develop proton therapy centers for advanced cancer treatment across ...

Today, the world pauses to recognise World Cancer Day, a day not just to raise awareness but to ignite action, inspire ...

As you navigate the challenges of prostate cancer and erectile dysfunction, remember that you are not alone. With advances in ...

Increase in QOL and decrease in sexual function are among the benefits and risks, respectively, of adding SADT to EBRT for intermediate-risk prostate cancer.

In Meraouna et al.'s study, the failure-free survival rate was 66% at 3 years of follow-up. Regarding treatment-related morbidities, 12.3% of patients experienced grade 3 genitourinary (GU) toxicity, ...